Patent ID: 11896646
Assignee: NAMMI THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A

Claim 4:
5. The nanocarrier of claim 4, further comprising a helper lipid, whereby the helper lipid is selected from the group consisting of the chloride salt of 1,2-dioleoyl-3-trimethylammonium-propane, 1,2-dioleyloxy-3-dimethylaminopropane, 1,2-dilinoleyloxy-3-dimethylaminopropane, 2,2-dilinoleyl-4-dimethylaminoethyl-[1,3]-dioxolane, 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine, 1,2-dioleoyl-sn-glycero-3-phosphocholine, cholesterol, N-[(methoxy poly(ethylene glycol)2000)carbamyI]-1,2-dimyristyloxlpropyl-3-amine, cholesteryl hemisuccinate, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine, 1 2-distearoyl- sn-glycero-3-phosphocholine and 4-(2-aminoethyl)-morpholino-cholesterolhemisuccinate.